112 related articles for article (PubMed ID: 17237624)
1. [Changes of MELD: can exceed Child-Pugh's authority?].
Lee JS
Korean J Hepatol; 2006 Dec; 12(4):475-8. PubMed ID: 17237624
[No Abstract] [Full Text] [Related]
2. [Usefulness of DeltaMELD/month for prediction of the mortality in the first episode of variceal bleeding patients with liver cirrhosis: comparison with CTP, MELD score and DeltaCTP/month].
Bae WK; Lee JS; Kim NH; Kim KA; Moon YS; Oh MK
Korean J Hepatol; 2007 Mar; 13(1):51-60. PubMed ID: 17380075
[TBL] [Abstract][Full Text] [Related]
3. Assessment of prognosis of cirrhosis.
Durand F; Valla D
Semin Liver Dis; 2008 Feb; 28(1):110-22. PubMed ID: 18293281
[TBL] [Abstract][Full Text] [Related]
4. [Clinical usefulness of DeltaMELD to predict the survival of patients with liver cirrhosis].
Eun SH; Kim YS; Jang JY; Cheon YG; Kim YS; Cho YD; Lee JS; Lee MS; Kim JH; Shim CS; Kim BS
Korean J Hepatol; 2006 Dec; 12(4):530-8. PubMed ID: 17237631
[TBL] [Abstract][Full Text] [Related]
5. Hypermetabolism predicts reduced transplant-free survival independent of MELD and Child-Pugh scores in liver cirrhosis.
Mathur S; Peng S; Gane EJ; McCall JL; Plank LD
Nutrition; 2007 May; 23(5):398-403. PubMed ID: 17395427
[TBL] [Abstract][Full Text] [Related]
6. Child, MELD, hyponatremia, and now portal pressure.
Blendis L
Gastroenterology; 2006 May; 130(6):1920-1; discussion 1921-2. PubMed ID: 16697756
[No Abstract] [Full Text] [Related]
7. Aetiology of cirrhosis of the liver has an impact on survival predicted by the Model of End-stage Liver Disease score.
Angermayr B; Luca A; König F; Bertolini G; Ploner M; Gridelli B; Ulbrich G; Reiberger T; Bosch J; Peck-Radosavljevic M
Eur J Clin Invest; 2009 Jan; 39(1):65-71. PubMed ID: 19087131
[TBL] [Abstract][Full Text] [Related]
8. Predictions and outcomes for the critically ill patient with cirrhosis: is it time to settle on the SOFA and let jaundiced views on outcome MELD away?
Warrillow SJ
Crit Care Med; 2010 Nov; 38(11):2259-60. PubMed ID: 20959755
[No Abstract] [Full Text] [Related]
9. Indocyanine green clearance test and model for end-stage liver disease score of patients with liver cirrhosis.
Sheng QS; Lang R; He Q; Yang YJ; Zhao DF; Chen DZ
Hepatobiliary Pancreat Dis Int; 2009 Feb; 8(1):46-9. PubMed ID: 19208514
[TBL] [Abstract][Full Text] [Related]
10. Assessment of the prognosis of cirrhosis: Child-Pugh versus MELD.
Durand F; Valla D
J Hepatol; 2005; 42 Suppl(1):S100-7. PubMed ID: 15777564
[No Abstract] [Full Text] [Related]
11. Selecting an optimal prognostic system for liver cirrhosis: the model for end-stage liver disease and beyond.
Huo TI; Lee SD; Lin HC
Liver Int; 2008 May; 28(5):606-13. PubMed ID: 18433390
[TBL] [Abstract][Full Text] [Related]
12. Improved outcome of adult recipients with a high model for end-stage liver disease score and a small-for-size graft.
Yi NJ; Suh KS; Lee HW; Shin WY; Kim J; Kim W; Kim YJ; Yoon JH; Lee HS; Lee KU
Liver Transpl; 2009 May; 15(5):496-503. PubMed ID: 19399732
[TBL] [Abstract][Full Text] [Related]
13. The model for end-stage liver disease (MELD) predicts survival of liver cirrhosis patients after discharge to hospice.
Antaki F; Lukowski A
J Clin Gastroenterol; 2007 Apr; 41(4):412-5. PubMed ID: 17413612
[TBL] [Abstract][Full Text] [Related]
14. Factors that predict survival in patients with cirrhosis considered for liver transplantation.
Samada Suarez M; Hernández Perera JC; Ramos Robaina L; Barroso Márquez L; González Rapado L; Cepero Valdés M; Hernández Rivero H; Abdo Cuza A; Valdés AR; Pérez Bernal J; Bernardos A
Transplant Proc; 2008 Nov; 40(9):2965-7. PubMed ID: 19010161
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for mortality after surgery in patients with cirrhosis.
Teh SH; Nagorney DM; Stevens SR; Offord KP; Therneau TM; Plevak DJ; Talwalkar JA; Kim WR; Kamath PS
Gastroenterology; 2007 Apr; 132(4):1261-9. PubMed ID: 17408652
[TBL] [Abstract][Full Text] [Related]
16. Model for end-stage liver disease-sodium predicts prognosis in patients with chronic severe hepatitis B.
Cai CJ; Chen HA; Lu MQ; Chen GH
Chin Med J (Engl); 2008 Oct; 121(20):2065-9. PubMed ID: 19080277
[TBL] [Abstract][Full Text] [Related]
17. Assessing the short- and long-term prognosis of patients with cirrhosis and acute variceal bleeding.
Sempere L; Palazón JM; Sánchez-Payá J; Pascual S; de Madaria E; Poveda MJ; Carnicer F; Zapater P; Pérez-Mateo M
Rev Esp Enferm Dig; 2009 Apr; 101(4):236-48. PubMed ID: 19492899
[TBL] [Abstract][Full Text] [Related]
18. Elevated soluble tumor necrosis factor receptor 75 concentrations identify patients with liver cirrhosis at risk of death.
Grünhage F; Rezori B; Neef M; Lammert F; Sauerbruch T; Spengler U; Reichel C
Clin Gastroenterol Hepatol; 2008 Nov; 6(11):1255-62. PubMed ID: 18995216
[TBL] [Abstract][Full Text] [Related]
19. Model for end-stage liver disease score to serum sodium ratio index as a prognostic predictor and its correlation with portal pressure in patients with liver cirrhosis.
Huo TI; Wang YW; Yang YY; Lin HC; Lee PC; Hou MC; Lee FY; Lee SD
Liver Int; 2007 May; 27(4):498-506. PubMed ID: 17403190
[TBL] [Abstract][Full Text] [Related]
20. Response to "MELD score and serum sodium in the prediction of survival of patients with cirrhosis awaiting liver transplantation".
Coltart I; Austin M; Shawcross DL
Gut; 2008 Jul; 57(7):1024-5. PubMed ID: 18559393
[No Abstract] [Full Text] [Related]
[Next] [New Search]
